BMA :: Doctors have lost confidence in government, says consultants’ leader
Doctors are angry, have lost confidence in the UK Government, and morale is at an all time low, the BMA?s consultants? leader said.
Doctors are angry, have lost confidence in the UK Government, and morale is at an all time low, the BMA?s consultants? leader said.
AIDS Healthcare Foundation (AHF), the US? largest provider of HIV/AIDS healthcare, education and prevention and operator of free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, today praised Merck for its decision to offer to reduce the price of its antiretroviral drug, efavirenz (marketed outside the US under the brand name Strocrin), in Thailand, but chided the multinational drug company for making the price cut offer contingent upon the Government of Thailand revoking a compulsory license it had issued in November 2006 for the manufacture and/or importation of a generic version of the drug.
The American College of Physicians today gave its strong support to the bipartisan High-Need Physician Workforce Incentives Act of 2007. The six-part bill introduced today by Reps. Michael C. Burgess, MD, and Henry Cuellar of Texas focuses on workforce issues of physicians.
The following is GlaxoSmithKline?s [NYSE:GSK] response to editorials written in the New England Journal of Medicine (NEJM) regarding Avandia? for the treatment of type 2 diabetes.
Paying hospitals extra money does not appear to significantly improve the way they treat heart attack patients or how well those patients do. But giving hospitals the information that they need to improve heart attack care does help.
Dr. Christopher Millett and colleagues investigated whether the introduction of a pay-for-performance incentive would improve the quality of care received by people with diabetes who smoke.
The University of Washington (UW) announced the creation of the Institute for Health Metrics and Evaluation, a new research center that will conduct independent, rigorous evaluations of health programs worldwide.
Nutrition 21, Inc. (NASDAQ: NXXI) announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome?, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).
Bayer HealthCare, a subsidiary of Bayer AG (NYSE: BAY), and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced that Nexavar? (sorafenib) tablets significantly extended overall survival in patients with hepatocellular carcinoma (HCC), or primary liver cancer versus those taking placebo by 44%.
Veterans returning from Iraq and Afghanistan have a wide range of health concerns, including a 55 percent prevalence of mental health issues, reports a study in the May Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).